Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

Transplant Rev (Orlando). 2024 Dec;38(4):100875. doi: 10.1016/j.trre.2024.100875. Epub 2024 Aug 5.

Abstract

Cytomegalovirus (CMV) infection remains a significant challenge in solid organ transplantation (SOT). The last international consensus guidelines on the management of CMV in SOT were published in 2018, highlighting the need for revision to incorporate recent advances, notably in cell-mediated immunity monitoring, which could alter the current standard of care. A working group including members from the Group for the Study of Infection in Transplantation and the Immunocompromised Host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Transplantation (SET), developed consensus-based recommendations for managing CMV infection in SOT recipients. Recommendations were classified based on evidence strength and quality using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. The final recommendations were endorsed through a consensus meeting and approved by the expert panel.

Keywords: Cytomegalovirus; Expert; Infection; Prevention; Recommendations; SOT; Transplantation.

Publication types

  • Review

MeSH terms

  • Adult
  • Antiviral Agents* / therapeutic use
  • Cytomegalovirus Infections*
  • Humans
  • Immunocompromised Host*
  • Organ Transplantation* / adverse effects
  • Practice Guidelines as Topic

Substances

  • Antiviral Agents